Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 300

1.

Indirect costs of depression and other mental and behavioural disorders for Australia from 2015 to 2030.

Schofield D, Cunich M, Shrestha R, Tanton R, Veerman L, Kelly S, Passey M.

BJPsych Open. 2019 May 3;5(3):e40. doi: 10.1192/bjo.2019.26.

2.

Intellectual disability and autism: socioeconomic impacts of informal caring, projected to 2030.

Schofield D, Zeppel MJB, Tanton R, Veerman JL, Kelly SJ, Passey ME, Shrestha RN.

Br J Psychiatry. 2019 Sep 16:1-7. doi: 10.1192/bjp.2019.204. [Epub ahead of print]

PMID:
31524109
3.

Chimpanzee face recognition from videos in the wild using deep learning.

Schofield D, Nagrani A, Zisserman A, Hayashi M, Matsuzawa T, Biro D, Carvalho S.

Sci Adv. 2019 Sep 4;5(9):eaaw0736. doi: 10.1126/sciadv.aaw0736. eCollection 2019 Sep.

4.

Groundwater heat pump feasibility in shallow urban aquifers: Experience from Cardiff, UK.

Boon DP, Farr GJ, Abesser C, Patton AM, James DR, Schofield DI, Tucker DG.

Sci Total Environ. 2019 Aug 8;697:133847. doi: 10.1016/j.scitotenv.2019.133847. [Epub ahead of print]

PMID:
31491627
5.

Preclinical development of a high affinity α-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular α-synuclein and attenuate α-synuclein spreading in vivo.

Schofield DJ, Irving L, Calo L, Bogstedt A, Rees G, Nuccitelli A, Narwal R, Petrone M, Roberts J, Brown L, Cusdin F, Dosanjh B, Lloyd C, Dobson C, Gurrell I, Fraser G, McFarlane M, Rockenstein E, Spencer B, Masliah E, Spillantini MG, Tan K, Billinton A, Vaughan T, Chessell I, Perkinton MS.

Neurobiol Dis. 2019 Aug 21;132:104582. doi: 10.1016/j.nbd.2019.104582. [Epub ahead of print]

PMID:
31445162
6.

The productivity gains associated with a junk food tax and their impact on cost-effectiveness.

Carter HE, Schofield DJ, Shrestha R, Veerman L.

PLoS One. 2019 Jul 22;14(7):e0220209. doi: 10.1371/journal.pone.0220209. eCollection 2019.

7.

The indirect costs of ischemic heart disease through lost productive life years for Australia from 2015 to 2030: results from a microsimulation model.

Schofield D, Cunich M, Shrestha R, Passey M, Veerman L, Tanton R, Kelly S.

BMC Public Health. 2019 Jun 21;19(1):802. doi: 10.1186/s12889-019-7086-5.

8.

The Diagnosis of Feline Leukaemia Virus (FeLV) Infection in Owned and Group-Housed Rescue Cats in Australia.

Westman M, Norris J, Malik R, Hofmann-Lehmann R, Harvey A, McLuckie A, Perkins M, Schofield D, Marcus A, McDonald M, Ward M, Hall E, Sheehy P, Hosie M.

Viruses. 2019 May 31;11(6). pii: E503. doi: 10.3390/v11060503.

9.

Long-term economic impacts of exome sequencing for suspected monogenic disorders: diagnosis, management, and reproductive outcomes.

Schofield D, Rynehart L, Shresthra R, White SM, Stark Z.

Genet Med. 2019 May 21. doi: 10.1038/s41436-019-0534-x. [Epub ahead of print]

PMID:
31110331
10.

Antibodies binding the head domain of P2X4 inhibit channel function and reverse neuropathic pain.

Williams WA, Linley JE, Jones CA, Shibata Y, Snijder A, Button J, Hatcher JP, Huang L, Taddese B, Thornton P, Schofield DJ, Thom G, Popovic B, Dosanjh B, Wilkinson T, Hughes J, Dobson CL, Groves MA, Webster CI, Billinton A, Vaughan TJ, Chessell I.

Pain. 2019 Sep;160(9):1989-2003. doi: 10.1097/j.pain.0000000000001587.

PMID:
31045747
11.

Productivity costs of cardiovascular disease mortality across disease types and socioeconomic groups.

Carter HE, Schofield D, Shrestha R.

Open Heart. 2019 Feb 16;6(1):e000939. doi: 10.1136/openhrt-2018-000939. eCollection 2019.

12.

Septal dysembryoplastic neuroepithelial tumor: a comprehensive clinical, imaging, histopathologic, and molecular analysis.

Chiang JCH, Harreld JH, Tanaka R, Li X, Wen J, Zhang C, Boué DR, Rauch TM, Boyd JT, Chen J, Corbo JC, Bouldin TW, Elton SW, Liu LL, Schofield D, Lee SC, Bouffard JP, Georgescu MM, Dossani RH, Aguiar MA, Sances RA, Saad AG, Boop FA, Qaddoumi I, Ellison DW.

Neuro Oncol. 2019 Jun 10;21(6):800-808. doi: 10.1093/neuonc/noz037.

PMID:
30726976
13.

Correction to: Effectiveness of a new model of primary care management on knee pain and function in patients with knee osteoarthritis: Protocol for THE PARTNER STUDY.

Hunter DJ, Hinman RS, Bowden JL, Egerton T, Briggs AM, Bunker SJ, Kasza J, Forbes AB, French SD, Pirotta M, Schofield DJ, Zwar NA, Bennell KL; PARTNER Study Team.

BMC Musculoskelet Disord. 2018 Dec 20;19(1):443. doi: 10.1186/s12891-018-2362-6.

14.

Economic costs of informal care for people with chronic diseases in the community: Lost income, extra welfare payments, and reduced taxes in Australia in 2015-2030.

Schofield D, Shrestha RN, Zeppel MJB, Cunich MM, Tanton R, Veerman JL, Kelly SJ, Passey ME.

Health Soc Care Community. 2019 Mar;27(2):493-501. doi: 10.1111/hsc.12670. Epub 2018 Oct 30.

PMID:
30378213
15.

Correction: Does genomic sequencing early in the diagnostic trajectory make a difference? A follow-up study of clinical outcomes and cost-effectiveness.

Stark Z, Schofield D, Martyn M, Rynehart L, Shrestha R, Alam K, Lunke S, Tan TY, Gaff CL, White SM.

Genet Med. 2019 Feb;21(2):516. doi: 10.1038/s41436-018-0078-5.

PMID:
30158691
16.

The Population Cost-Effectiveness of Weight Watchers with General Practitioner Referral Compared with Standard Care.

Lymer S, Schofield D, Cunich M, Lee CMY, Fuller N, Caterson I, Colagiuri S.

Obesity (Silver Spring). 2018 Aug;26(8):1261-1269. doi: 10.1002/oby.22216.

17.

Origin of Many-Body Vibrational Frequency Shifts in Water Clusters.

Heindel JP, Knodel ES, Schofield DP.

J Phys Chem A. 2018 Aug 23;122(33):6724-6735. doi: 10.1021/acs.jpca.8b04380. Epub 2018 Aug 8.

PMID:
30028609
18.

Therapeutic Monoclonal Antibodies to Complex Membrane Protein Targets: Antigen Generation and Antibody Discovery Strategies.

Dodd RB, Wilkinson T, Schofield DJ.

BioDrugs. 2018 Aug;32(4):339-355. doi: 10.1007/s40259-018-0289-y. Review.

PMID:
29934752
19.

Economic evaluation of genomic sequencing in the paediatric population: a critical review.

Alam K, Schofield D.

Eur J Hum Genet. 2018 Sep;26(9):1241-1247. doi: 10.1038/s41431-018-0175-6. Epub 2018 May 24.

20.

The long-term economic impacts of arthritis through lost productive life years: results from an Australian microsimulation model.

Schofield D, Cunich M, Shrestha RN, Tanton R, Veerman L, Kelly S, Passey ME.

BMC Public Health. 2018 May 24;18(1):654. doi: 10.1186/s12889-018-5509-3.

21.

Does genomic sequencing early in the diagnostic trajectory make a difference? A follow-up study of clinical outcomes and cost-effectiveness.

Stark Z, Schofield D, Martyn M, Rynehart L, Shrestha R, Alam K, Lunke S, Tan TY, Gaff CL, White SM.

Genet Med. 2019 Jan;21(1):173-180. doi: 10.1038/s41436-018-0006-8. Epub 2018 May 15. Erratum in: Genet Med. 2018 Aug 29;:.

PMID:
29765138
22.

Effectiveness of a new model of primary care management on knee pain and function in patients with knee osteoarthritis: Protocol for THE PARTNER STUDY.

Hunter DJ, Hinman RS, Bowden JL, Egerton T, Briggs AM, Bunker SJ, Kasza J, Forbes AB, French SD, Pirotta M, Schofield DJ, Zwar NA, Bennell KL; PARTNER Study Team.

BMC Musculoskelet Disord. 2018 Apr 30;19(1):132. doi: 10.1186/s12891-018-2048-0. Erratum in: BMC Musculoskelet Disord. 2018 Dec 20;19(1):443.

23.

Psychological distress increases the risk of falling into poverty amongst older Australians: the overlooked costs-of-illness.

Callander EJ, Schofield DJ.

BMC Psychol. 2018 Apr 17;6(1):16. doi: 10.1186/s40359-018-0230-7.

24.

The economic impacts of using adalimumab (Humira® ) for reducing pain in people with ankylosing spondylitis: A microsimulation study for Australia.

Schofield D, Shrestha R, Cunich M.

Int J Rheum Dis. 2018 May;21(5):1106-1113. doi: 10.1111/1756-185X.13277. Epub 2018 Apr 3.

PMID:
29611342
25.

Whole-exome sequencing reanalysis at 12 months boosts diagnosis and is cost-effective when applied early in Mendelian disorders.

Ewans LJ, Schofield D, Shrestha R, Zhu Y, Gayevskiy V, Ying K, Walsh C, Lee E, Kirk EP, Colley A, Ellaway C, Turner A, Mowat D, Worgan L, Freckmann ML, Lipke M, Sachdev R, Miller D, Field M, Dinger ME, Buckley MF, Cowley MJ, Roscioli T.

Genet Med. 2018 Dec;20(12):1564-1574. doi: 10.1038/gim.2018.39. Epub 2018 Mar 29.

PMID:
29595814
26.

Integrating exome sequencing into a diagnostic pathway for epileptic encephalopathy: Evidence of clinical utility and cost effectiveness.

Palmer EE, Schofield D, Shrestha R, Kandula T, Macintosh R, Lawson JA, Andrews I, Sampaio H, Johnson AM, Farrar MA, Cardamone M, Mowat D, Elakis G, Lo W, Zhu Y, Ying K, Morris P, Tao J, Dias KR, Buckley M, Dinger ME, Cowley MJ, Roscioli T, Kirk EP, Bye A, Sachdev RK.

Mol Genet Genomic Med. 2018 Mar;6(2):186-199. doi: 10.1002/mgg3.355. Epub 2018 Jan 4.

27.

Cumulative culture in nonhumans: overlooked findings from Japanese monkeys?

Schofield DP, McGrew WC, Takahashi A, Hirata S.

Primates. 2018 Mar;59(2):113-122. doi: 10.1007/s10329-017-0642-7. Epub 2017 Dec 27. Review.

28.

Application of next-generation sequencing to improve cancer management: A review of the clinical effectiveness and cost-effectiveness.

Tan O, Shrestha R, Cunich M, Schofield DJ.

Clin Genet. 2018 Mar;93(3):533-544. doi: 10.1111/cge.13199. Epub 2018 Feb 8. Review.

PMID:
29265354
29.

Prioritising the application of genomic medicine.

Doble B, Schofield DJ, Roscioli T, Mattick JS.

NPJ Genom Med. 2017 Nov 21;2:35. doi: 10.1038/s41525-017-0037-0. eCollection 2017. Review.

30.

Cost-effectiveness of massively parallel sequencing for diagnosis of paediatric muscle diseases.

Schofield D, Alam K, Douglas L, Shrestha R, MacArthur DG, Davis M, Laing NG, Clarke NF, Burns J, Cooper ST, North KN, Sandaradura SA, O'Grady GL.

NPJ Genom Med. 2017;2. pii: 4. doi: 10.1038/s41525-017-0006-7. Epub 2017 Mar 3.

31.

Improving Fab' fragment retention in an autonucleolytic Escherichia coli strain by swapping periplasmic nuclease translocation signal from OmpA to DsbA.

Schofield DM, Sirka E, Keshavarz-Moore E, Ward JM, Nesbeth DN.

Biotechnol Lett. 2017 Dec;39(12):1865-1873. doi: 10.1007/s10529-017-2425-z. Epub 2017 Sep 5.

32.

Detection of Bacillus anthracis spores from environmental water using bioluminescent reporter phage.

Nguyen C, Makkar R, Sharp NJ, Page MA, Molineux IJ, Schofield DA.

J Appl Microbiol. 2017 Nov;123(5):1184-1193. doi: 10.1111/jam.13569. Epub 2017 Sep 21.

33.

Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions.

Tan TY, Dillon OJ, Stark Z, Schofield D, Alam K, Shrestha R, Chong B, Phelan D, Brett GR, Creed E, Jarmolowicz A, Yap P, Walsh M, Downie L, Amor DJ, Savarirayan R, McGillivray G, Yeung A, Peters H, Robertson SJ, Robinson AJ, Macciocca I, Sadedin S, Bell K, Oshlack A, Georgeson P, Thorne N, Gaff C, White SM.

JAMA Pediatr. 2017 Sep 1;171(9):855-862. doi: 10.1001/jamapediatrics.2017.1755.

34.

Coverage of Nutrition Interventions Intended for Infants and Young Children Varies Greatly across Programs: Results from Coverage Surveys in 5 Countries.

Leyvraz M, Aaron GJ, Poonawala A, van Liere MJ, Schofield D, Myatt M, Neufeld LM.

J Nutr. 2017 May;147(5):995S-1003S. doi: 10.3945/jn.116.245407. Epub 2017 Apr 12. Review.

35.

The budget impact of using enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg to prevent recurrent cardiovascular events.

Zhang W, Han Y, Fort JG, Schofield D, Tursi JP.

J Med Econ. 2017 Jun;20(6):592-598. doi: 10.1080/13696998.2017.1289940. Epub 2017 Feb 23.

PMID:
28145783
36.

Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement.

Stark Z, Schofield D, Alam K, Wilson W, Mupfeki N, Macciocca I, Shrestha R, White SM, Gaff C.

Genet Med. 2017 Aug;19(8):867-874. doi: 10.1038/gim.2016.221. Epub 2017 Jan 26.

PMID:
28125081
38.

The Productivity Costs of Premature Mortality Due to Cancer in Australia: Evidence from a Microsimulation Model.

Carter HE, Schofield DJ, Shrestha R.

PLoS One. 2016 Dec 12;11(12):e0167521. doi: 10.1371/journal.pone.0167521. eCollection 2016.

39.

The long-term productivity impacts of all cause premature mortality in Australia.

Carter HE, Schofield D, Shrestha R.

Aust N Z J Public Health. 2017 Apr;41(2):137-143. doi: 10.1111/1753-6405.12604. Epub 2016 Nov 20.

PMID:
27868363
40.

The indirect costs of back problems (dorsopathies) in Australians aged 45 to 64 years from 2015 to 2030: results from a microsimulation model, Health&WealthMOD2030.

Schofield D, Cunich MM, Shrestha RN, Tanton R, Veerman L, Kelly SJ, Passey ME.

Pain. 2016 Dec;157(12):2816-2825.

PMID:
27842049
41.

Working Beyond the Traditional Retirement Age: The Influence of Health on Australia's Older Workers.

Schofield DJ, Callander EJ, Kelly SJ, Shrestha RN.

J Aging Soc Policy. 2017 May-Jun;29(3):235-244. doi: 10.1080/08959420.2016.1246319. Epub 2016 Oct 12.

PMID:
27732170
42.

Economic costs of chronic disease through lost productive life years (PLYs) among Australians aged 45-64 years from 2015 to 2030: results from a microsimulation model.

Schofield D, Shrestha RN, Cunich MM, Tanton R, Veerman L, Kelly SJ, Passey ME.

BMJ Open. 2016 Sep 22;6(9):e011151. doi: 10.1136/bmjopen-2016-011151.

43.

Tectonic and climatic considerations for deep geological disposal of radioactive waste: A UK perspective.

McEvoy FM, Schofield DI, Shaw RP, Norris S.

Sci Total Environ. 2016 Nov 15;571:507-21. doi: 10.1016/j.scitotenv.2016.07.018. Epub 2016 Jul 22.

44.

The risk of falling into poverty after developing heart disease: a survival analysis.

Callander EJ, Schofield DJ.

BMC Public Health. 2016 Jul 15;16:570. doi: 10.1186/s12889-016-3240-5.

45.

A Delivery Model for Home Fortification of Complementary Foods with Micronutrient Powders: Innovation in the Context of Vietnamese Health System Strengthening.

Nguyen M, Poonawala A, Leyvraz M, Berger J, Schofield D, Nga TT, Van TK, Hoa do TB, Wieringa FT.

Nutrients. 2016 Apr 29;8(5). pii: E259. doi: 10.3390/nu8050259.

46.

Detecting cell lysis using viscosity monitoring in E. coli fermentation to prevent product loss.

Newton JM, Schofield D, Vlahopoulou J, Zhou Y.

Biotechnol Prog. 2016 Jul 8;32(4):1069-76. doi: 10.1002/btpr.2292. Epub 2016 May 17.

47.

Promoter engineering to optimize recombinant periplasmic Fab' fragment production in Escherichia coli.

Schofield DM, Templar A, Newton J, Nesbeth DN.

Biotechnol Prog. 2016 Jul 8;32(4):840-7. doi: 10.1002/btpr.2273. Epub 2016 May 6.

PMID:
27071365
48.

Development of radiodetection systems towards miniaturised quality control of PET and SPECT radiopharmaceuticals.

Taggart MP, Tarn MD, Esfahani MM, Schofield DM, Brown NJ, Archibald SJ, Deakin T, Pamme N, Thompson LF.

Lab Chip. 2016 Apr 26;16(9):1605-16. doi: 10.1039/c6lc00099a.

PMID:
27044712
49.

Pathways into chronic multidimensional poverty amongst older people: a longitudinal study.

Callander EJ, Schofield DJ.

BMC Geriatr. 2016 Mar 7;16:62. doi: 10.1186/s12877-016-0236-z.

50.

The impact of poverty on self-efficacy: an Australian longitudinal study.

Callander EJ, Schofield DJ.

Occup Med (Lond). 2016 Jun;66(4):320-5. doi: 10.1093/occmed/kqw017. Epub 2016 Mar 3.

PMID:
26944594

Supplemental Content

Loading ...
Support Center